Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins.

October 10, 2019 — An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no ...

In the complex and fast-paced world of healthcare, customers face the challenge of staying up-to-date with the most advanced systems while also keeping costs down. Providers now have a solution from Canon Medical Systems USA: the Alphenix Encore Plus Program. The program enables customers to upgrade their aging angiography systems to the latest technology while maintaining many existing parts, delivering clinical excellence, operational continuity and cost savings.

Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Valiant TAAA Stent Graft System for minimally invasive repair of thoracoabdominal aortic aneurysm (TAAA). A TAAA is a complex condition causing a bulging of the aorta, which extends from the chest down into the abdomen.

Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of Cardiology’s (ACC) Annual Scientific Session. Drachman will serve as vice chair for ACC.21 and ACC.22 and transition to chair for ACC.23 and ACC.24.